Literature DB >> 14660141

HIV incidence and risk behaviours after voluntary HIV counselling and testing (VCT) among adults aged 19-35 years living in peri-urban communities around Chiang Mai city in northern Thailand, 1999.

S Kawichai1, C Beyrer, C Khamboonruang, D D Celentano, C Natpratan, K Rungruengthanakit, K E Nelson.   

Abstract

The Thai government began HIV voluntary counselling and testing (VCT) in all provinces in 1992. We evaluated HIV incidence after participants utilized VCT and its effect on risk behaviours among northern Thai adults aged 19-35 years. A total of 924 men and 1,327 women volunteered to participate in the study. Subjects were counseled, interviewed (socio-demographic, HIV risk behaviour, and HIV testing history), and tested for HIV infection at baseline and at 6 months follow-up. All participants were provided group pre-test counselling; HIV test results were provided in individual confidential post-test counselling. Overall, 329 of 391 men and 621 of 669 women who reported a prior HIV test before participating in our study reported negative results at the previous test. Of these, nine men and 13 women tested positive at baseline, giving incidence rates of 1.04 and 0.69 per 100 person years (PY), respectively. Recent risk behaviour was rare; as a result, the effects of VCT on risk behaviours among the study participants could not be determined. The HIV incidence after VCT among this study population is substantial. Studies to investigate factors associated with HIV incidence among VCT clients could provide insights for more effective HIV prevention.

Entities:  

Mesh:

Year:  2004        PMID: 14660141     DOI: 10.1080/09540120310001633949

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  8 in total

Review 1.  A meta-analysis of the efficacy of HIV/AIDS prevention interventions in Asia, 1995-2009.

Authors:  Judy Y Tan; Tania B Huedo-Medina; Michelle R Warren; Michael P Carey; Blair T Johnson
Journal:  Soc Sci Med       Date:  2011-10-01       Impact factor: 4.634

2.  Changes in HIV risk behavior and seroincidence among clients presenting for repeat HIV counseling and testing in Moshi, Tanzania.

Authors:  Suzanne P Fiorillo; Keren Z Landman; Alison C Tribble; Antipas Mtalo; Dafrosa K Itemba; Jan Ostermann; Nathan M Thielman; John A Crump
Journal:  AIDS Care       Date:  2012-03-01

Review 3.  Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries.

Authors:  Virginia A Fonner; Julie Denison; Caitlin E Kennedy; Kevin O'Reilly; Michael Sweat
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 4.  A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia.

Authors:  A M Foss; M Hossain; P T Vickerman; C H Watts
Journal:  Sex Transm Infect       Date:  2007-10-11       Impact factor: 3.519

5.  Knowledge, attitudes, and practices of voluntary HIV counseling and testing among rural migrants in Shanghai, China.

Authors:  Na He; Jinling Zhang; Jinjian Yao; Xiuhong Tian; Genming Zhao; Qingwu Jiang; Roger Detels
Journal:  AIDS Educ Prev       Date:  2009-12

6.  Determinants of condom uptake among HIV voluntary counselling and testing clients: experiences from a hospital-based study in south India.

Authors:  Rebecca Myerson; Susanna M Makela; C Chandrasekhar; Siju Mathew; Sourabh Chakraborty
Journal:  BMC Health Serv Res       Date:  2012-01-11       Impact factor: 2.655

7.  HIV antibody testing and its correlates among heterosexual attendees of sexually transmitted disease clinics in China.

Authors:  Qiaoqin Ma; Xiaohong Pan; Gaofeng Cai; Jiezhe Yan; Masako Ono-Kihara; Masahiro Kihara
Journal:  BMC Public Health       Date:  2013-01-17       Impact factor: 3.295

8.  Survey of motivation for use of voluntary counseling and testing services for HIV in a high risk area of Shenyang, China.

Authors:  Ling Zhou; Junqiao Guo; Lijuan Fan; Jing Tian; Baosen Zhou
Journal:  BMC Health Serv Res       Date:  2009-02-05       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.